11/17/2014 - 6:48pm

November is a big month for me. In addition to Thanksgiving, my birthday and the anniversary of the first date my wife and I went on also are in November. On our first anniversary, my wife got me a really nice watch; I got her a $20 memory box from Papyrus. Somehow, she stuck with me anyway. Apparently, I had — and still do have — quite a bit to learn. You could learn a lot from the 20 women featured in this issue.

11/17/2014 - 6:48pm

Pepsi has entered the artisanal beverage space with Caleb’s Kola, a drink made with cane sugar, kola nut extract and a blend of spices packaged in 10-oz. glass bottles. Each bottle has 110 calories and 29 grams of sugar.

11/17/2014 - 6:48pm

In response to the growing popularity of soft drinks sweetened with cane sugar and the spike in demand for “MexiCoke,” Coke has started distributing the product itself in the United States.

11/17/2014 - 6:48pm

It’s a new era for carbonated beverages. Sales have been falling for a decade as consumers have shifted away from traditional sodas sweetened with high-fructose corn syrup and are avoiding diet sodas due to concerns about artificial sweeteners.

11/17/2014 - 6:47pm

Taking its cue from the runway looks during Spring 2014 Fashion Week, Maybelline New York launched in October its new Creamy Mattes Color Sensational collection.

11/17/2014 - 6:47pm

It may account for the smallest percentage of total color cosmetics, but don’t let that fool you. Lip color is currently the darling of the cosmetics category.

11/17/2014 - 6:47pm

Earlier this year iHealth Lab launched iHealth Align, a mobile blood-glucose monitor that plugs directly into a smartphone, and displays and stores readings using the iHealth Gluco-Smart app. 

11/17/2014 - 6:47pm

Nipro Diagnostics introduced its True Metrix Self-Monitoring and the True Metrix Pro Professional Monitoring blood-glucose systems. 

11/17/2014 - 6:47pm

Four-in-10 U.S. adults are expected to develop Type 2 diabetes at some point in their lifetime, according to a new study published in The Lancet Diabetes & Endocrinology in August, suggesting that as many as 126 million consumers will be looking for treatment options, including self-monitoring their condition at home.